全球胜肽合成市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計胜肽合成市場將從 2025 年的 66.9 億美元成長到 2034 年的 139.8 億美元，2026 年至 2034 年的複合年成長率為 8.54%。

由於製藥和生物技術領域的研究活動日益活躍，全球胜肽合成市場穩步成長。肽在藥物開發、診斷和治療應用中發揮著至關重要的作用。慢性病盛行率的上升正在加速對肽類藥物的需求。生命科學研究投入的增加進一步推動了重點地區市場的成長。

成長要素包括固相合成技術和自動化程度的進步。製藥公司在標靶治療和個人化醫療中依賴肽類藥物。化妝品配方中胜肽類藥物的日益廣泛應用也推動了需求的成長。此外，科學研究和政府資助也在推動合成技術的創新。

隨著全球生物製藥開發平臺的不斷擴展，未來前景依然強勁。經濟高效的合成方法的開發和純化技術的改進將推動生產規模的擴大。精準醫療的日益普及將進一步促進胜肽類藥物的應用。隨著醫學研究的不斷深入，預計市場將持續成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球胜肽合成市場：按類型分類

• 市場分析、洞察與預測
• 低於75%
• 75-85%
• 超過85%

第5章 全球胜肽合成市場：依產品分類

• 市場分析、洞察與預測
• 裝置
• 試劑和耗材
• 其他

第6章 全球胜肽合成市場：依技術分類

• 市場分析、洞察與預測
• 固相胜肽合成（SPPS）
• 溶液相胜肽合成（SPS）
• 液相肽合成（LPPS）
• 雜交和重組

第7章 全球胜肽合成市場：依應用分類

• 市場分析、洞察與預測
• 治療藥物
• 診斷與研究

第8章 全球胜肽合成市場：依最終用戶分類

• 市場分析、洞察與預測
• 製藥和生物技術公司
• 契約製造組織（CMO）或受託研究機構（CRO）
• 學術研究機構

第9章 全球胜肽合成市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 亞太其他地區
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第10章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第11章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • PolyPeptide Group
  • Merck KGaA
  • Thermo Fisher Scientific
  • Enamine Ltd
  • Alfa Chemistry
  • CEM Corporation
  • GenScript
  • AAPPTec
  • Bachem Holding
  • AnaSpec Inc
  • Biotage

The Peptide Synthesis Market size is expected to reach USD 13.98 Billion in 2034 from USD 6.69 Billion (2025) growing at a CAGR of 8.54% during 2026-2034.

The Global Peptide Synthesis market has grown steadily due to increasing research activities in pharmaceuticals and biotechnology. Peptides play a critical role in drug development, diagnostics, and therapeutic applications. Rising prevalence of chronic diseases has accelerated demand for peptide-based drugs. Expanding investments in life sciences research further support market growth across major regions.

Growth drivers include advancements in solid-phase synthesis technologies and automation. Pharmaceutical companies rely on peptides for targeted therapies and personalized medicine. Increasing use of peptides in cosmetic formulations also contributes to expanding demand. Additionally, academic research and government funding enhance innovation in synthesis techniques.

Future prospects appear strong as biopharmaceutical pipelines expand globally. Development of cost-efficient synthesis methods and improved purification technologies will drive scalability. Growing focus on precision medicine will further increase peptide utilization. The market is projected to witness sustained growth aligned with advancements in medical research.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Under 75%
• 75-85%
• Above 85%

By Product

• Equipment
• Reagents and Consumables
• Others

By Technology

• Solid-Phase Peptide Synthesis (SPPS)
• Solution-Phase Synthesis (SPS)
• Liquid-Phase Peptide Synthesis (LPPS)
• Hybrid and Recombinant

By Application

• Therapeutics
• Diagnosis and Research

By End User

• Pharmaceutical and Biotechnology Companies
• Contract Manufacturing Organization (CMO) or Contract Research Organization (CRO)
• Academic and Research Institutes

COMPANIES PROFILED

• PolyPeptide Group, Merck KGaA, Thermo Fisher Scientific, Enamine Ltd, Alfa Chemistry, CEM Corporation, GenScript, AAPPTec, Bachem Holding, AnaSpec Inc, Biotage
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PEPTIDE SYNTHESIS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Under 75% Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. 75-85% Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Above 85% Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PEPTIDE SYNTHESIS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Product
• 5.2. Equipment Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Reagents and Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PEPTIDE SYNTHESIS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Technology
• 6.2. Solid-Phase Peptide Synthesis (SPPS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Solution-Phase Synthesis (SPS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Liquid-Phase Peptide Synthesis (LPPS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Hybrid and Recombinant Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PEPTIDE SYNTHESIS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Therapeutics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Diagnosis and Research Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PEPTIDE SYNTHESIS MARKET: BY END USER 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End User
• 8.2. Pharmaceutical and Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Contract Manufacturing Organization (CMO) or Contract Research Organization (CRO) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Academic and Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL PEPTIDE SYNTHESIS MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Type
  • 9.2.2 By Product
  • 9.2.3 By Technology
  • 9.2.4 By Application
  • 9.2.5 By End User
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Type
  • 9.3.2 By Product
  • 9.3.3 By Technology
  • 9.3.4 By Application
  • 9.3.5 By End User
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Type
  • 9.4.2 By Product
  • 9.4.3 By Technology
  • 9.4.4 By Application
  • 9.4.5 By End User
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Type
  • 9.5.2 By Product
  • 9.5.3 By Technology
  • 9.5.4 By Application
  • 9.5.5 By End User
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Type
  • 9.6.2 By Product
  • 9.6.3 By Technology
  • 9.6.4 By Application
  • 9.6.5 By End User
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL PEPTIDE SYNTHESIS INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 PolyPeptide Group
  • 11.2.2 Merck KGaA
  • 11.2.3 Thermo Fisher Scientific
  • 11.2.4 Enamine Ltd
  • 11.2.5 Alfa Chemistry
  • 11.2.6 CEM Corporation
  • 11.2.7 GenScript
  • 11.2.8 AAPPTec
  • 11.2.9 Bachem Holding
  • 11.2.10 AnaSpec Inc
  • 11.2.11 Biotage